-
1
-
-
77953594954
-
Drugs dispensed in primary care during pregnancy: A record-linkage analysis in Tayside Scotland
-
Irvine L, Flynn RW, Libby G, Crombie IK, Evans JM. Drugs dispensed in primary care during pregnancy: a record-linkage analysis in Tayside, Scotland. Drug Saf. 2010;33:593-604.
-
(2010)
Drug Saf
, vol.33
, pp. 593-604
-
-
Irvine, L.1
Flynn, R.W.2
Libby, G.3
Crombie, I.K.4
Evans, J.M.5
-
2
-
-
84865858101
-
Prescribing without evidence: Pregnancy
-
Thomas SH, Yates LM. Prescribing without evidence: pregnancy. Br J Clin Pharmacol. 2012;74:691-697.
-
(2012)
Br J Clin Pharmacol
, vol.74
, pp. 691-697
-
-
Thomas, S.H.1
Yates, L.M.2
-
3
-
-
0022460809
-
Low-molecular-weight heparin in venous thrombosis during pregnancy
-
Priollet P, Roncato M, Aiach M, Housset E, Poissonnier MH, Chavinie J. Low-molecular-weight heparin in venous thrombosis during pregnancy. Br J Haematol. 1986;63:605-606.
-
(1986)
Br J Haematol
, vol.63
, pp. 605-606
-
-
Priollet, P.1
Roncato, M.2
Aiach, M.3
Housset, E.4
Poissonnier, M.H.5
Chavinie, J.6
-
4
-
-
0027043228
-
Use of low molecular weight heparin for prophylaxis and treatment and treatment of thromboembolism in pregnancy
-
Gillis S, Shushan A, Eldor A. Use of low molecular weight heparin for prophylaxis and treatment and treatment of thromboembolism in pregnancy. Int J Gynaecol Obestet. 1992; 39: 297-301.
-
(1992)
Int J Gynaecol Obestet
, vol.39
, pp. 297-301
-
-
Gillis, S.1
Shushan, A.2
Eldor, A.3
-
5
-
-
22144466236
-
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy
-
Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106:401-407.
-
(2005)
Blood
, vol.106
, pp. 401-407
-
-
Greer, I.A.1
Nelson-Piercy, C.2
-
6
-
-
84873558091
-
Anticoagulant therapy for venous thromboembolism during pregnancy: A systematic review and a meta-analysis of the literature
-
Romualdi E, Dentali F, Rancan E, Squizzato A, Steidl L, Middeldorp S, Ageno W. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature. J Thromb Haemost. 2013;11:270-281.
-
(2013)
J Thromb Haemost
, vol.11
, pp. 270-281
-
-
Romualdi, E.1
Dentali, F.2
Rancan, E.3
Squizzato, A.4
Steidl, L.5
Middeldorp, S.6
Ageno, W.7
-
7
-
-
49849101762
-
Where do we go now with LMWH use in obstetric care?
-
Patel JP, Hunt BJ. Where do we go now with LMWH use in obstetric care? J Thromb Haemost. 2008; 6: 1461-1467.
-
(2008)
J Thromb Haemost
, vol.6
, pp. 1461-1467
-
-
Patel, J.P.1
Hunt, B.J.2
-
8
-
-
25144516296
-
Pregnancy-induced changes in pharmacokinetics: A mechanistic-based approach
-
Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet. 2005;44:989-1008.
-
(2005)
Clin Pharmacokinet
, vol.44
, pp. 989-1008
-
-
Anderson, G.D.1
-
10
-
-
84856809942
-
VTE, thrombophilia, antithrombotic therapy and pregnancy: Antithrombotic therapy and prevention of thrombosis, American College of Chest Physicians Guidelines
-
Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy and pregnancy: antithrombotic therapy and prevention of thrombosis, American College of Chest Physicians Guidelines. Chest. 2012;141(suppl):e691s-e736s.
-
(2012)
Chest
, vol.141
, Issue.SUPPL.
-
-
Bates, S.M.1
Greer, I.A.2
Middeldorp, S.3
Veenstra, D.L.4
Prabulos, A.M.5
Vandvik, P.O.6
-
11
-
-
0028333023
-
The use of low molecular weight heparin for thromboprophylaxis in pregnancy
-
Sturridge F, de Swiet M, Letsky E. The use of low molecular weight heparin for thromboprophylaxis in pregnancy. Br J Obstet Gynaecol. 1994;101:69-71.
-
(1994)
Br J Obstet Gynaecol
, vol.101
, pp. 69-71
-
-
Sturridge, F.1
De Swiet, M.2
Letsky, E.3
-
12
-
-
0031055634
-
Thromboprophylaxis with low molecular weight heparin (dalteparin) in high risk pregnancies
-
Hunt BJ, Doughty H, Majurndar G, Copplestone A, Kerslake S, Buchanan N, Hughes G, Khamashta M. Thromboprophylaxis with low molecular weight heparin (dalteparin) in high risk pregnancies. Thromb Haemost. 1997; 77: 39-43.
-
(1997)
Thromb Haemost
, vol.77
, pp. 39-43
-
-
Hunt, B.J.1
Doughty, H.2
Majurndar, G.3
Copplestone, A.4
Kerslake, S.5
Buchanan, N.6
Hughes, G.7
Khamashta, M.8
-
13
-
-
0030957087
-
Low-molecular-weight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at high risk
-
Nelson-Piercy C, Letsky EA, de Swiet M. Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol. 1997;176: 1062-1068.
-
(1997)
Am J Obstet Gynecol
, vol.176
, pp. 1062-1068
-
-
Nelson-Piercy, C.1
Letsky, E.A.2
De Swiet, M.3
-
15
-
-
0032738711
-
Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy
-
Casele HL, Laifer SA, Woelkers DA, Venkataramanan R. Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol. 1999;181(pt 1):1113-1117.
-
(1999)
Am J Obstet Gynecol
, vol.181
, Issue.PART 1
, pp. 1113-1117
-
-
Casele, H.L.1
Laifer, S.A.2
Woelkers, D.A.3
Venkataramanan, R.4
-
16
-
-
0035083961
-
Accumulation of low molecular mass heparin during prophylactic treatment in pregnancy
-
Bremme K, van Rooijen M, Yu A, Blombäck M. Accumulation of low molecular mass heparin during prophylactic treatment in pregnancy. Blood Coagul Fibrinolysis. 2001;12:149-155.
-
(2001)
Blood Coagul Fibrinolysis
, vol.12
, pp. 149-155
-
-
Bremme, K.1
Van Rooijen, M.2
Yu, A.3
Blombäck, M.4
-
17
-
-
0034655194
-
Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients: A prospective cohort study
-
Crowther MA, Spitzer K, Julian J, Ginsberg J, Johnston M, Crowther R, Laskin C. Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients: a prospective cohort study. Thromb Res. 2000;98:133-138.
-
(2000)
Thromb Res
, vol.98
, pp. 133-138
-
-
Crowther, M.A.1
Spitzer, K.2
Julian, J.3
Ginsberg, J.4
Johnston, M.5
Crowther, R.6
Laskin, C.7
-
18
-
-
0033812190
-
Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy
-
Ellison J, Walker ID, Greer IA. Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy. BJOG. 2000;107:1116-1121.
-
(2000)
BJOG
, vol.107
, pp. 1116-1121
-
-
Ellison, J.1
Walker, I.D.2
Greer, I.A.3
-
19
-
-
0036754654
-
Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy a case series
-
Rodie VA, Thomson AJ, Stewart FM, Quinn AJ, Walker ID, Greer IA. Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy a case series: 2002. Br J Obstet Gynaecol. 2002;109:1020-1024.
-
(2002)
Br J Obstet Gynaecol.
, vol.109
, pp. 1020-1024
-
-
Rodie, V.A.1
Thomson, A.J.2
Stewart, F.M.3
Quinn, A.J.4
Walker, I.D.5
Greer, I.A.6
-
20
-
-
14844328732
-
Thromboprophylaxis with unmonitored intermediate-dose low molecular weight heparin in pregnancies with a previous arterial or venous thrombotic event
-
Hunt BJ, Gattens M, Khamashta M, Nelson-Piercy C, Almeida A. Thromboprophylaxis with unmonitored intermediate-dose low molecular weight heparin in pregnancies with a previous arterial or venous thrombotic event. Blood Coagul Fibrinolysis. 2003;14:735-739.
-
(2003)
Blood Coagul Fibrinolysis
, vol.14
, pp. 735-739
-
-
Hunt, B.J.1
Gattens, M.2
Khamashta, M.3
Nelson-Piercy, C.4
Almeida, A.5
-
21
-
-
0037331214
-
Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy
-
Jacobsen AF, Qvigstad E, Sandset PM. Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy. BJOG. 2003;110:139-144.
-
(2003)
BJOG
, vol.110
, pp. 139-144
-
-
Jacobsen, A.F.1
Qvigstad, E.2
Sandset, P.M.3
-
22
-
-
0037870646
-
A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy
-
Sephton V, Farquharson RG, Topping J, Quenby SM, Cowan C, Back DJ, Toh CH. A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy. Obstet Gynecol. 2003;101:1307-1311.
-
(2003)
Obstet Gynecol
, vol.101
, pp. 1307-1311
-
-
Sephton, V.1
Farquharson, R.G.2
Topping, J.3
Quenby, S.M.4
Cowan, C.5
Back, D.J.6
Toh, C.H.7
-
23
-
-
6344241111
-
Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy: A pharmacokinetic study
-
Norris LA, Bonnar J, Smith MP, Steer PJ, Savidge G. Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy: a pharmacokinetic study. Thromb Haemost. 2004;92:791-796.
-
(2004)
Thromb Haemost
, vol.92
, pp. 791-796
-
-
Norris, L.A.1
Bonnar, J.2
Smith, M.P.3
Steer, P.J.4
Savidge, G.5
-
24
-
-
4444279681
-
Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy
-
Ensom MH, Stephenson MD. Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy. J Soc Gynecol Investig. 2004;11:377-383.
-
(2004)
J Soc Gynecol Investig
, vol.11
, pp. 377-383
-
-
Ensom, M.H.1
Stephenson, M.D.2
-
25
-
-
17444380411
-
A protocol for the use of enoxaparin during pregnancy: Results from 85 pregnancies including 13 multiple gestation pregnancies
-
Huxtable LM, Tafreshi MJ, Ondreyco SM. A protocol for the use of enoxaparin during pregnancy: results from 85 pregnancies including 13 multiple gestation pregnancies. Clin Appl Thromb Hemost. 2005;11:171-181.
-
(2005)
Clin Appl Thromb Hemost
, vol.11
, pp. 171-181
-
-
Huxtable, L.M.1
Tafreshi, M.J.2
Ondreyco, S.M.3
-
26
-
-
55449127268
-
Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis
-
Fox NS, Laughon SK, Bender SD, Saltzman DH, Rebarber A. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis. Obstet Gynecol. 2008;112:884-889.
-
(2008)
Obstet Gynecol
, vol.112
, pp. 884-889
-
-
Fox, N.S.1
Laughon, S.K.2
Bender, S.D.3
Saltzman, D.H.4
Rebarber, A.5
-
27
-
-
55049111238
-
Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy
-
N?́Ainle F, Wong A, Appleby N, Byrne B, Regan C, Hassan T, Milner M, O'Sullivan A, White B, O?Donnell J. Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy. Blood Coagul Fibrinolysis. 2008;19:689-692.
-
(2008)
Blood Coagul Fibrinolysis
, vol.19
, pp. 689-692
-
-
Ńainle, F.1
Wong, A.2
Appleby, N.3
Byrne, B.4
Regan, C.5
Hassan, T.6
Milner, M.7
Osullivan, A.8
White, B.9
Odonnell, J.10
-
28
-
-
79955844576
-
Interpreting population pharmacokinetic-pharmacodynamic analyses: A clinical viewpoint
-
Duffull SB, Wright DF, Winter HR. Interpreting population pharmacokinetic-pharmacodynamic analyses: a clinical viewpoint. Br J Clin Pharmacol. 2011;71:807-814.
-
(2011)
Br J Clin Pharmacol
, vol.71
, pp. 807-814
-
-
Duffull, S.B.1
Wright, D.F.2
Winter, H.R.3
-
29
-
-
84862651945
-
Leveraging physiological data from literature into a pharmacokinetic model to support informative clinical study design in pregnant women
-
van Hasselt JG, Green B, Morrish GA. Leveraging physiological data from literature into a pharmacokinetic model to support informative clinical study design in pregnant women. Pharm Res. 2012;29:1609-1617.
-
(2012)
Pharm Res
, vol.29
, pp. 1609-1617
-
-
Van Hasselt, J.G.1
Green, B.2
Morrish, G.A.3
-
31
-
-
84884673733
-
-
European Medicines Agency Evaluation of Medicines for Human Use. Innovative drug development approaches: final report from the EMEA/CHMP Think Tank Group on Innovative Drug Development 2007 Accessed August 27, 2011
-
European Medicines Agency, Evaluation of Medicines for Human Use. Innovative drug development approaches: final report from the EMEA/CHMP Think Tank Group on Innovative Drug Development, 2007. http://www.ema.europa.eu/docs/ en-GB/document-library/Other/2009/10/WC500004913.pdf. Accessed August 27, 2011.
-
-
-
-
32
-
-
79955844576
-
Interpreting population pharmacokinetic-pharmacodynamic analyses: A clinical viewpoint
-
Duffull SB, Wright DF, Winter HR. Interpreting population pharmacokinetic-pharmacodynamic analyses: a clinical viewpoint. Br J Clin Pharmacol. 2011;71:807-814.
-
(2011)
Br J Clin Pharmacol
, vol.71
, pp. 807-814
-
-
Duffull, S.B.1
Wright, D.F.2
Winter, H.R.3
-
33
-
-
0021269554
-
The population approach to pharmacokinetic data analysis: Rationale and standard data analysis methods
-
Sheiner LB. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods. Drug Metab Rev. 1984;15:153-171.
-
(1984)
Drug Metab Rev
, vol.15
, pp. 153-171
-
-
Sheiner, L.B.1
-
34
-
-
0025836658
-
Population pharmacokinetics: Theory and practice
-
Aarons L. Population pharmacokinetics: theory and practice. Br J Clin Pharmacol. 1991;32:669-670.
-
(1991)
Br J Clin Pharmacol
, vol.32
, pp. 669-670
-
-
Aarons, L.1
-
35
-
-
58549105374
-
Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109)
-
ANRS 12109
-
Hirt D, Urien S, Ekouévi DK, Rey E, Arrivé E, Blanche S, Amani-Bosse C, Nerrienet E, Gray G, Kone M, Leang SK, McIntyre J, Dabis F, Tréluyer JM; ANRS 12109. Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). Clin Pharmacol Ther. 2009;85:182-189.
-
(2009)
Clin Pharmacol Ther
, vol.85
, pp. 182-189
-
-
Hirt, D.1
Urien, S.2
Ekouévi, D.K.3
Rey, E.4
Arrivé, E.5
Blanche, S.6
Amani-Bosse, C.7
Nerrienet, E.8
Gray, G.9
Kone, M.10
Leang, S.K.11
McIntyre, J.12
Dabis, F.13
Tréluyer, J.M.14
-
36
-
-
70349119891
-
Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria
-
Tarning J, McGready R, Lindegardh N, Ashley EA, Pimanpanarak M, Kamanikom B, Annerberg A, Day NP, Stepniewska K, Singhasivanon P, White NJ, Nosten F. Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother. 2009;53:3837-3846.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 3837-3846
-
-
Tarning, J.1
McGready, R.2
Lindegardh, N.3
Ashley, E.A.4
Pimanpanarak, M.5
Kamanikom, B.6
Annerberg, A.7
Day, N.P.8
Stepniewska, K.9
Singhasivanon, P.10
White, N.J.11
Nosten, F.12
-
40
-
-
72449195769
-
-
R Development Core Team. R: a language and environment for statistical computing
-
R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: A Foundation for Statistical Computing; 2006. (http://www.R-project.org).
-
(2006)
Vienna Austria: A Foundation for Statistical Computing
-
-
-
42
-
-
49949084605
-
Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy
-
Lebaudy C, Hulot JS, Amoura Z, Costedoat-Chalumeau N, Serreau R, Ankri A, Conard J, Cornet A, Dommergues M, Piette JC, Lechat P. Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy. Clin Pharmacol Ther. 2008;84:370-377.
-
(2008)
Clin Pharmacol Ther
, vol.84
, pp. 370-377
-
-
Lebaudy, C.1
Hulot, J.S.2
Amoura, Z.3
Costedoat-Chalumeau, N.4
Serreau, R.5
Ankri, A.6
Conard, J.7
Cornet, A.8
Dommergues, M.9
Piette, J.C.10
Lechat, P.11
-
43
-
-
35948961224
-
The management of antenatal venous thromboembolism in the UK and Ireland: A prospective multi-centre survey
-
Voke JM, Keidan J, Parvod S, Spencer NH, Hunt BJ. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multi-centre survey. Br J Haematol. 2007; 139: 545-558.
-
(2007)
Br J Haematol
, vol.139
, pp. 545-558
-
-
Voke, J.M.1
Keidan, J.2
Parvod, S.3
Spencer, N.H.4
Hunt, B.J.5
-
44
-
-
38949151562
-
Antenatal pulmonary embolism: Risk factors, management and outcomes
-
UKOSS
-
Knight M; UKOSS. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG. 2008;115:453-461.
-
(2008)
BJOG
, vol.115
, pp. 453-461
-
-
Knight, M.1
-
45
-
-
84872294995
-
Weightadjusted dosing of tinzaparin in pregnancy
-
Gibson PS, Newell K, Sam DX, Mansoor A, Jiang X, Tang S, Ross S. Weightadjusted dosing of tinzaparin in pregnancy. Thromb Res. 2013;131:e71-e75.
-
(2013)
Thromb Res
, vol.131
-
-
Gibson, P.S.1
Newell, K.2
Sam, D.X.3
Mansoor, A.4
Jiang, X.5
Tang, S.6
Ross, S.7
-
46
-
-
84871064820
-
Women's views on and adherence to enoxaparin during pregnancy and the puerperium
-
Patel JP, Auyeung V, Patel RK, Marsh MS, Green B, Arya R, Davies JGD. Women's views on and adherence to enoxaparin during pregnancy and the puerperium. J Thromb Haemost. 2012; 10: 2526-2534.
-
(2012)
J Thromb Haemost
, vol.10
, pp. 2526-2534
-
-
Patel, J.P.1
Auyeung, V.2
Patel, R.K.3
Marsh, M.S.4
Green, B.5
Arya, R.6
Davies, J.G.D.7
|